enzalutamide,
MDV 3100,
MDV-3100,
MDV3100,
Enzalutamide,
915087-33-1,
MDV3100,
MDV-3100,
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide,
MDV 3100,
XTANDI,
Enzalutamide (MDV3100),
MDV3100 (Enzalutamide),
UNII-93T0T9GKNU,
MDV3100 Enzalutamide,
93T0T9GKNU,
CHEBI:68534,
4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide,
4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide,
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide,
Benzamide,4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-,
Enzalutamide [USAN:INN],
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide,
Xtandi (TN),
PubChem19320,
Tube704,
Enzalutamide (JAN/USAN),
MDV3100, AldrichCPR,
MLS006010067,
SCHEMBL189749,
GTPL6812,
C21H16F4N4O2S,
CHEMBL1082407,
CTK8B6725,
EX-A046,
QCR-130,
WXCXUHSOUPDCQV-UHFFFAOYSA-N,
BCPP000169,
HMS3654L07,
NC-54,
AMX10212,
AOB87731,
ASP-9785,
MDV3100/MDV-3100,
ABP000459,
ANW-54164,
BBL102957,
BDBM50425732,
MFCD14155804,
s1250,
STL556766,
ZINC34806477,
AKOS015851022,
ACN-026804,
API0007596,
BCP9000901,
CS-0317,
DB08899,
RL05765,
SB20413,
KS-0000079W,
NCGC00263120-01,
AC-26924,
AK-72825,
AN-16279,
AS-17047,
BC660065,
BR-72825,
CJ-18592,
HY-70002,
MDV3100, 95%,
SC-69109,
SMR004701227,
AB0008149,
AX8165432,
TC-142909,
FT-0670957,
ST24028748,
SW219288-1,
W9480,
A25302,
D10218,
S-3847,
AB01565849_02,
SR-01000941580,
J-519668,
SR-01000941580-1,
BRD-K56851771-001-01-9,
MDV-3100, 915087-33-1,
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-me,
Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-,
n-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluo,
Enzalutamide [USAN],
D0M1YR,
D0QK5X,
Enzalutamide (AR inhibitor),
cc-412,
MDV3101,
A3003,
A10562,
C540278,
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide,